Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Shah Amit B., Chief Financial Officer. Insider active across 1 company, notably Oncotelic Therapeutics, Inc.. In total, 2 reports have been logged. Activity tracked since 8 July 2021. The latest transaction was disclosed on 8 July 2021 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations
Amit B. Shah serves as the Chief Financial Officer at Oncotelic Therapeutics, Inc. He oversees the company's financial management, including budgeting and risk management. Shah brings expertise in finance and accounting, contributing to strategic decisions that promote Oncotelic's growth and sustainability. His commitment to financial transparency enhances trust among investors and stakeholders.